The role of CD24 in various human epithelial neoplasias

被引:85
|
作者
Lim, SC
Oh, SH
机构
[1] Chosun Univ Hosp, Dept Pathol, Coll Med, Gwangju City 501410, South Korea
[2] Chosun Univ Hosp, Res Ctr Resistant Cells, Coll Med, Gwangju City 501410, South Korea
关键词
epithelial tumor; gastrointestinal tract; ovary; breast;
D O I
10.1016/j.prp.2005.05.004
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD24 is a small, heavily glycosylated glycosylphosphatidylinositol-linked cell surface protein, which is expressed in hematologic malignancies and in a large variety of solid tumors. It appears to function as a ligand of P-selectin, an adhesion molecule present in activated platelets and endothelial cells. The authors aimed at evaluating CD24 protein expression in adenoma and adenocarcinoma of the stomach, colon, gallbladder, ovary, and breast to establish a correlation with clinicopathologic data. Staining was evaluated using four degrees of positivity (negative, weakly, moderately, strongly positive), and the staining patterns (membranous vs. intracytoplasmic) were analyzed for statistical analysis. The present study clearly demonstrates that CD24 is abundantly expressed in adenocarcinoma compared to adenoma of the colon and breast. Moreover, the positivity degree of CD24 expression increases with positive nodal status in advanced gastric carcinoma. Intracytoplasmic CD24 expression was found to be highly associated with adenocarcinoma of the colon, gallbladder, and ovary compared to the adenoma group of those organs, and with the positive nodal status compared to the negative nodal status of the colonic adenocarcinoma. We conclude that the degree of positivity and the staining pattern of CD24 constitute an important molecular marker for various epithelial neoplasms, which could help to define malignant transformation and to predict lymph node metastasis. (c) 2005 Elsevier GmbH. All rights reserved.
引用
收藏
页码:479 / 486
页数:8
相关论文
共 50 条
  • [31] CD24 Expression in Colorectal Carcinoma
    Karahan, Nermin
    Barut, Ibrahim
    Baspinar, Sirin
    Kapucuoglu, Nilgun
    Tarhan, Omer
    Candir, Ozden
    ERCIYES MEDICAL JOURNAL, 2008, 30 (04) : 225 - 231
  • [32] CD24 is an Important Oncogene in the Colon
    Naumov, Inna
    Kazanov, Diana
    Altevogt, Peter
    Kraus, Sarah
    Arber, Nadir
    GASTROENTEROLOGY, 2011, 140 (05) : S816 - S816
  • [33] Deep sequencing of mRNA in CD24(-) and CD24(+) mammary carcinoma Mvt1 cell line
    Rostoker, Ran
    Jayaprakash, Anitha D.
    Sachidanandam, Ravi
    LeRoith, Derek
    GENOMICS DATA, 2015, 5 : 399 - 401
  • [34] CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas
    Deng, Jianping
    Gao, Guodong
    Wang, Liang
    Wang, Tao
    Yu, Jia
    Zhao, Zhenwei
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
  • [35] Targeting CD24 in Cancer Immunotherapy
    Chen, Wenwen
    Hu, Zhigang
    Guo, Zhigang
    BIOMEDICINES, 2023, 11 (12)
  • [36] EXPRESSION OF CD24 IN OVARIAN CANCER
    Lukacs, J.
    Soltesz, B.
    Nagy, B.
    Poka, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A489 - A489
  • [37] CD24 tracks divergent pluripotent states in mouse and human cells
    Nika Shakiba
    Carl A. White
    Yonatan Y. Lipsitz
    Ayako Yachie-Kinoshita
    Peter D Tonge
    Samer M. I. Hussein
    Mira C. Puri
    Judith Elbaz
    James Morrissey-Scoot
    Mira Li
    Javier Munoz
    Marco Benevento
    Ian M. Rogers
    Jacob H. Hanna
    Albert J. R. Heck
    Bernd Wollscheid
    Andras Nagy
    Peter W Zandstra
    Nature Communications, 6
  • [38] CD24 tracks divergent pluripotent states in mouse and human cells
    Shakiba, Nika
    White, Carl A.
    Lipsitz, Yonatan Y.
    Yachie-Kinoshita, Ayako
    Tonge, Peter D.
    Hussein, Samer M. I.
    Puri, Mira C.
    Elbaz, Judith
    Morrissey-Scoot, James
    Li, Mira
    Munoz, Javier
    Benevento, Marco
    Rogers, Ian M.
    Hanna, Jacob H.
    Heck, Albert J. R.
    Wollscheid, Bernd
    Nagy, Andras
    Zandstra, Peter W.
    NATURE COMMUNICATIONS, 2015, 6
  • [39] Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development
    Elghetany, MT
    Patel, J
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (04) : 348 - 349
  • [40] CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias (vol 11, e0158021, 2016)
    Pei, X.
    Zhu, J.
    Yang, R.
    Tan, Z.
    An, M.
    Shi, J.
    PLOS ONE, 2017, 12 (04):